Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Autor: Birtas Atesoglu E; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Gulbas Z; Division of Hematology, Anadolu Medical Center, Kocaeli, Turkey., Uzay A; Division of Hematology, Acibadem Atakent Hospital, Istanbul, Turkey., Ozcan M; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey., Ozkalemkas F; Department of Internal Medicine, Division of Hematology, Uludag University Medical Faculty, Bursa, Turkey., Dal MS; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital, Ankara, Turkey., Kalyon H; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Akay OM; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Deveci B; Division of Hematology, Medstar Hospital, Antalya, Turkey., Bekoz H; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey., Sevindik OG; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey., Toptas T; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey., Yilmaz F; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey., Koyun D; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey., Alkis N; Division of Hematology, Bursa City Hospital, Bursa, Turkey., Alacacioglu I; Department of Internal Medicine, Division of Hematology, Dokuz Eylul University Medical Faculty, Izmir, Turkey., Sonmez M; Department of Internal Medicine, Division of Hematology, Karadeniz Technical University Medical Faculty, Trabzon, Turkey., Yavasoglu I; Department of Internal Medicine, Division of Hematology, Adnan Menderes University Medical Faculty, Aydin, Turkey., Tombak A; Department of Internal Medicine, Division of Hematology, Mersin University Medical Faculty, Mersin, Turkey., Mehtap O; Department of Internal Medicine, Division of Hematology, Kocaeli University Medical Faculty, Kocaeli, Turkey., Kurnaz F; Division of Hematology, Kocaeli Medicalpark Hospital, Kocaeli, Turkey., Yuce OK; Department of Internal Medicine, Division of Hematology, Akdeniz University Medical Faculty, Antalya, Turkey., Karakus V; Division of Hematology, Antalya Research and Training Hospital, Antalya, Turkey., Turgut M; Department of Internal Medicine, Division of Hematology, Ondokuzmayıs University Medical Faculty, Samsun, Turkey., Kurekci DD; Department of Internal Medicine, Division of Hematology, Ondokuzmayıs University Medical Faculty, Samsun, Turkey., Ayer M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey., Keklik M; Department of Internal Medicine, Division of Hematology, Erciyes University Medical Faculty, Kayseri, Turkey., Buyuktas D; Division of Hematology, V.K.V. American Hospital, Istanbul, Turkey., Ozbalak M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey., Ferhanoglu B; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.

Publikováno v: Hematological oncology [Hematol Oncol] 2023 Oct; Vol. 41 (4), pp. 663-673. Date of Electronic Publication: 2023 May 22.